GP admits to falsifying clinical trial of insomnia drug.
The BMJ.
Clare
C
Dyer
D002986:Clinical Trials as Topic / Q000941:ethics*; D004353:Drug Evaluation, Preclinical / Q000941:ethics*; D005464:Fluorobenzenes / Q000009:adverse effects / Q000627:therapeutic use*; D058005:General Practitioners / Q000941:ethics* / Q000331:legislation & jurisprudence; D006801:Humans; D008297:Male; D009660:Northern Ireland; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D015871:Scientific Misconduct / Q000331:legislation & jurisprudence*; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D016896:Treatment Outcome
D005464:Fluorobenzenes; D010880:Piperidines; D012702:Serotonin Antagonists; C079049:volinanserin